Medical Spanish Standardization in U.S. Medical Schools: Consensus Statement From a Multidisciplinary Expert Panel

Pilar Ortega1, Lisa Diamond, Marco A Alemán

  • 1P. Ortega is clinical assistant professor, Departments of Emergency Medicine and Medical Education, University of Illinois College of Medicine, Chicago, Illinois; ORCID: http://orcid.org/0000-0002-5136-1805. L. Diamond is assistant attending, Department of Psychiatry and Behavioral Sciences, Immigrant Health and Cancer Disparities Service, Hospital Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York. M.A. Alemán is professor, Department of Medicine, University of North Carolina School of Medicine, and director, Comprehensive Advanced Medical Program of Spanish, Chapel Hill, North Carolina. J. Fatás-Cabeza is associate professor, Department of Spanish and Portuguese, and director, Undergraduate Translation and Interpretation Program, University of Arizona, Tucson, Arizona. D. Magaña is assistant professor, Department of Literature, Languages and Cultures, University of California, Merced, Merced, California. V. Pazo is instructor, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, and course director, Medical Spanish, Harvard University, Boston, Massachusetts. N. Pérez is director, School of Medicine Special Programs and Hispanic Center of Excellence, University of Texas Medical Branch, Galveston, Texas. J.A. Girotti is assistant professor, Department of Medical Education, and director, Hispanic Center of Excellence, University of Illinois College of Medicine, Chicago, Illinois. E. Ríos is president, National Hispanic Health Foundation, Washington, DC.

Summary

Medical Spanish education lacks standards, risking patient safety. Experts recommend national guidelines for curriculum, competency, and assessment to improve communication with Spanish-speaking patients.

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
761
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
182
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
321
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
212